Latest News
Ted Baker confirms 'hugging' probe as revenues dip
Scandal-hit Ted Baker confirmed on Thursday that it has appointed an independent law firm to carry out an investigation into reports of "forced hugging" by founder and chief executive Ray Kelvin, as it posted a dip in revenues.
Just Eat surprisingly demoted from FTSE 100, replaced by Spirax
Just Eat will be demoted from the FTSE 100 along with Royal Mail when the quarterly index reshuffle is completed later this month, resulting in Hiscox and Spirax-Sarco Engineering making their debuts on the blue chip benchmark.
London open: Stocks drop as Huawei CFO arrest sparks jitters
London stocks fell in early trade on Thursday, taking their cue from heavy losses in Asia amid renewed concerns about trade relations between the US and China.
Grainger shortlisted for TfL build-to-rent scheme
Grainger, the UK's largest listed residential landlord, on Thursday said it had been shortlisted as one of three companies by Transport for London (TfL) for a private rented sector partnership.
Ferrexpo declares decent special dividend
Ferrexpo announced a special dividend on Thursday, after reporting that it had continued to trade as expected in the second half of 2018.
ContourGlobal sells minority interest in Spanish solar assets
ContourGlobal has reached an agreement to sell a 49% interest in its 250 MW concentrated solar power facilities in the south west of Spain, it announced on Thursday, to a fund advised by Credit Suisse Energy Infrastructure Partners.
Euromoney to buy BoardEx and The Deal for $87.3m
Business information and events group Euromoney Institutional Investor has agreed to buy BoardEx and The Deal from parent company TheStreet for $87. 3m in cash.
Vodafone invites bondholders to sell up to £300m of their bonds
Vodafone Group announced an invitation to holders of the zero-coupon equity-linked bonds to offer to sell their bonds for cash on Thursday, at a purchase price to be determined pursuant to a modified Dutch auction procedure.
AstraZeneca offloads ciclesonide rights to Covis in $350m deal
AstraZeneca has completed an agreement with Covis Pharma to sell its rights to the medicines Alvesco (ciclesonide), used for the treatment of persistent asthma, and Omnaris and Zetonna (ciclesonide), used for the treatment of nasal symptoms associated with rhinitis.
London pre-open: Stocks seen lower as Huawei CFO arrest prompts trade war fears
London stocks were set for a downbeat open on Thursday, taking their cue from heavy losses in Asia amid renewed concerns about trade relations between the US and China.
Beazley estimates California wildfire costs at $40m
Specialist insurer Beazley on Thursday said its early estimate of the cost of claims from the recent California wildfires is $40m (£31m), net of reinsurance.
DS Smith profits swell in first half, AstraZeneca offloads ciclesonide rights for $350m
London open The FTSE 100 is expected to open 64 points lower on Thursday, having closed down 1. 44% at 6,821. 84 on Wednesday.
Thursday newspaper round-up: Huawei CFO, Facebook, KMPG, Capita
Canada has arrested Huawei’s global chief financial officer in Vancouver, where she is facing extradition to the US in a move likely to exacerbate tensions between the US and China. Meng Wanzhou, one of the vice-chairs on the Chinese technology company’s board and the daughter of the company founder Ren Zhengfei, was arrested on 1 December and a court hearing has been set for Friday, according to Canada’s department of justice. The arrest is reportedly related to violations of US sanctions.